Percutaneous delivery of liquid tetracycline using a thermal resurfacing drug delivery system for the treatment of festoons
Lasers in Surgery and Medicine · 2024
DOI: 10.1002/lsm.23786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, 2024. Verfasst von Margarita Safir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Shamir Medical Center, The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Tetracycline, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
To examine the effects of percutaneous tetracycline delivery to the malar area using a thermomechanical device (Tixel) in patients suffering from festoons.
Methods
This retrospective study included patients who underwent combination treatment with a thermomechanical device (Tixel) followed by application of topical tetracycline 1% at two private clinics between 2019 and 2023. Demographic and medical data, treatment parameters along with before and after treatment photographs were retrieved retrospectively. All patients were asked to answer a questionnaire, assessing self‐reported pre and posttreatment disturbance, patient global impression of change (PGIC) score, overall satisfaction with treatment, and the onset and duration of treatment effect. Finally, three masked reviewers evaluated and graded the severity of before and after treatment photographs.
Results
Twenty healthy patients received the combination treatment. The mean age was 59.4 ± 8.2 years (range: 45–72 years), and 90.0% ( n = 18) were female. The number of treatment sessions per patient ranged from 2 to 8, mean of 5.0 ± 1.9, performed at 5.4 ± 1.2‐week intervals. The masked reviewers' grading scores demonstrated a significant improvement (2.81 ± 1.3 before vs. 1.6 ± 1.1 after, p < 0.001). The self‐reported disturbance caused by the festoons improved significantly as well (4.7 ± 0.98 vs. 1.7 ± 1.1, p < 0.001). On the PGIC score, 85% (17/20) reported moderate (grade 5) to significant (grade 7) improvement of symptoms and life quality after treatment. Improvement onset was reported to occur 11.2 ± 6.6 days after the first treatment (range 2−30 days), and 90% (18/20) of the patients reported improvement lasting at least 4 months after completion of the second treatment.
Conclusions
Topical tetracycline application following Tixel treatment induced significant improvement in patient with festoons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Department, Shamir Medical Center, The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Military Medicine, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Division of Dermatology, Tel Aviv Sourasky Medical Center, The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Margarita Safir, Ofir Artzi
Zitieren
APA
Safir, M., Waizer, I., Safir, A., Hartstein, M. E., & Artzi, O. (2024). Percutaneous delivery of liquid tetracycline using a thermal resurfacing drug delivery system for the treatment of festoons. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23786
Vancouver
Safir M, Waizer I, Safir A, Hartstein ME, Artzi O. Percutaneous delivery of liquid tetracycline using a thermal resurfacing drug delivery system for the treatment of festoons. Lasers in Surgery and Medicine. 2024. doi:10.1002/lsm.23786
BibTeX
@article{Safir2024,
author = {Safir, Margarita and Waizer, Inbar and Safir, Ari and Hartstein, Morris E and Artzi, Ofir},
title = {Percutaneous delivery of liquid tetracycline using a thermal resurfacing drug delivery system for the treatment of festoons},
journal = {Lasers in Surgery and Medicine},
year = {2024},
doi = {10.1002/lsm.23786}
}
EUVIMED